Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Wiest Website

Jonathan S. Wiest, Ph.D.

Selected Publications

1)  Nelson DE, Faupel-Badger J, Phillips S, Belcher B, Chang S, Abrams DB, Kramer BS, White MC, O'Malley M, Varanasi AP, Fabian CJ, Wiest JS, Colditz GA, Hall K, Shields PG, Weitzel JN.
Future directions for postdoctoral training in cancer prevention: insights from a panel of experts.
Cancer Epidemiol. Biomarkers Prev. 23: 679-83, 2014.
2)  DeCicco-Skinner KL, Nolan SJ, Deshpande MM, Trovato EL, Dempsey TA, Wiest JS.
Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice.
PLoS ONE. 8: e56212, 2013.
3)  Mason JL, Lei M, Faupel-Badger JM, Ginsburg EP, Seger YR, Dijoseph L, Schnell JD, Wiest JS.
Outcome evaluation of the national cancer institute career development awards program.
J Cancer Educ. 28: 9-17, 2013.
4)  Decicco-Skinner K, Jung S, Tabib T, Gwilliam J, Alexander H, Goodheart S, Merchant A, Shan M, Garber C, Wiest J.
Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.
Carcinogenesis. 34: 2789-98, 2013.
5)  Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest JS.
TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.
PLoS ONE. 8: e66114, 2013.
6)  Faupel-Badger JM, van Bemmel DM, Wiest JS, Nelson DE.
Expanding cancer prevention education to national and international audiences: the National Cancer Institute's Principles and Practice of Cancer Prevention and Control annual summer course.
J Cancer Educ. 26: 619-25, 2011.
7)  Decicco-Skinner KL, Trovato EL, Simmons JK, Lepage PK, Wiest JS.
Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Oncogene. 30: 389-97, 2011.
8)  Amos CI, Pinney SM, Li Y, Kupert E, Lee J, de Andrade MA, Yang P, Schwartz AG, Fain PR, Gazdar A, Minna J, Wiest JS, Zeng D, Rothschild H, Mandal D, You M, Coons T, Gaba C, Bailey-Wilson JE, Anderson MW.
A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers.
Cancer Res. 70: 2359-67, 2010.
9)  You M, Wang D, Liu P, Vikis H, James M, Lu Y, Wang Y, Wang M, Chen Q, Jia D, Liu Y, Wen W, Yang P, Sun Z, Pinney SM, Zheng W, Shu XO, Long J, Gao YT, Xiang YB, Chow WH, Rothman N, Petersen GM, de Andrade M, Wu Y, Cunningham JM, Wiest JS, Fain PR, Schwartz AG, Girard L, Gazdar A, Gaba C, Rothschild H, Mandal D, Coons T, Lee J, Kupert E, Seminara D, Minna J, Bailey-Wilson JE, Amos CI, Anderson MW.
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene.
Clin. Cancer Res. 15: 2666-74, 2009.
10)  Liu Y, Liu P, Wen W, James MA, Wang Y, Bailey-Wilson JE, Amos CI, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Lee J, Seminara D, Minna J, Anderson MW, You M.
Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1.
Cancer Res. 69: 7844-50, 2009.
Click Here to View Expanded Bibliography.

This page was last updated on 5/20/2014.